MannKind to acquire scPharmaceuticals for $303M, expanding into cardiorenal medicine with Furoscix. Read more here.

The U.S. could take further stakes in companies similar to its equity investment in Intel, a top White House economic adviser ...

As students fill classrooms and get settled into dorms, university leaders say their focus is going beyond enrollment numbers ...

Titan Intech has changed its record date for determining shareholder eligibility for a stock split to September 8, 2025, from ...

Wall Street analysts don't expect the money alone to turn around Intel's business, which has suffered from years of declining ...

According to a new survey, nearly half of investors participating in 401(k) and similar workplace retirement savings plans ...

The U.S. once commandeered railroads, steel, and banks in crisis. Now Washington buys into Intel without one—laying bare the ...

Phoenix Financial Ltd., a leading Israel -based asset management, insurance, and investment company (TLV:PHOE) ("Phoenix ...

FCIcoin, a blockchain-native infrastructure platform for institutional trading, has announced its strategic commitment to ...

Lip-Bu Tan was anxiously preparing for the biggest meeting of his life. Just five months into his tenure as chief executive of Intel, Tan was already fighting for his job. A few days earlier, Donald ...

The federal auditor general is planning to release a report next year that examines the recruitment, retention and promotion ...

What happened to AI’s productivity promise? Investment is through the roof, but real returns haven’t materialized. Analysts ...